Clinical Study
Evaluation of Protocol Biopsy Utility 12 Months after Renal Transplantation: A Multicenter Observational Analysis
Table 3
Renal function according to time posttransplant.
| | Surveillance biopsy () | No surveillance biopsy () | valuea |
| eGFR, mL/min/1.73 m2 b | | | | Month 3 | 54 (20–107) | 49 (15–114) | 0.002 | Month 6 | 55 (21–119) | 52 (8–104) | 0.025 | Month 12 | 55 (16–138) | 49 (25–99) | 0.113 | Month 18 | 54 (26–128) | 53 (26–105) | 0.48 | Proteinuria, g/24 h | | | | Month 3 | 0.16 (0.00–2.18) | 0.25 (0.00–2.00) | 0.007 | Month 6 | 0.15 (0.00–5.00) | 0.18 (0.00–1.92) | 0.69 | Month 12 | 0.15 (0.00–2.26) | 0.20 (0.00–3.90) | 0.19 | Month 18 | 0.16 (0.00–10.70) | 0.16 (0.00–1.89) | 0.79 |
|
|
Values are shown as median (range).
aStudent’s t-test or Wilcoxon test.
baMDRD formula.
|